Share Issue/Capital Change • Jan 22, 2014
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 2656Y
ValiRx PLC
22 January 2014
22 January 2014
ValiRx Plc
("ValiRx" or the "Company")
Grant of options
ValiRx Plc (AIM: VAL), the AIM listed life science company with a focus on cancer diagnostics and therapeutics for personalised medicine, announces that on 21 January 2014 it granted 133,000,000 options over ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") to certain employees and directors of the Company, as set out in the table below.
| Name of director | Number of shares held | % of issued share capital | Number of existing options | Number of new options granted | Total options now held | Options held as % of issued share capital |
| Satu Vainikka | 22,324,198 | 0.76% | 11,000,000 | 24,000,000 | 35,000,000 | 1.20% |
| George Morris | 18,535,993 | 0.63% | 6,750,000 | 22,000,000 | 28,750,000 | 0.98% |
| Gerry Desler | 11,137,953 | 0.38% | 6,400,000 | 22,000,000 | 28,400,000 | 0.97% |
| Kevin Alexander | 6,421,940 | 0.22% | 6,400,000 | 20,000,000 | 26,400,000 | 0.90% |
| Oliver de Giorgio-Miller | 2,444,411 | 0.08% | 3,000,000 | 20,000,000 | 23,000,000 | 0.79% |
| Seppo Makinen | Nil | Nil | Nil | 8,000,000 | 8,000,000 | 0.27% |
| Total Directors | 60,864,494 | 2.08% | 33,550,000 | 116,000,000 | 149,550,000 | 5.12% |
| Others | Nil | Nil | 6,100,000 | 17,000,000 | 23,100,000 | 0.79% |
| Total | 60,864,495 | 2.08% | 46,050,000 | 133,000,000 | 172,650,000 | 5.91% |
The new options were granted under the Company's stock option plan and have an exercise price of 0.345p pence. The new options are exercisable from 21 January 2014 until 20 January 2024.
Following the grant of the new options, the total number of Ordinary Shares under option held by directors which could be issued is 149,550,000 Ordinary Shares, representing approximately 5.12 per cent. of the current issued share capital of the Company.
In addition, a further 17,000,000 options have been granted to others at an exercise price of 0.345 pence which are exercisable until 20 January 2024.
As at the date of this announcement the Company has a total of 179,050,000 shares under option.
The issued share capital of the Company comprises 2,921,043,420 ordinary shares of 0.1 pence each.
For more information, please contact:
| Dr Satu Vainikka | ValiRx | Tel: +44 (0) 20 3008 4416 www.ValiRx.com |
| Liam Murray Avi Robinson |
Nominated Adviser Cairn Financial Advisers |
Tel: +44 (0) 20 7148 7900 |
| David Hart Mark Treharne |
Broker Daniel Stewart & Company |
Tel: +44 (0) 20 7776 6550 |
| Tarquin Edwards | Investor Relations Peckwater PR |
Tel: +44 (0) 7879 458 364 [email protected] |
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBXGDBBBDBGSD
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.